Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of converting kidney transplant recipients to everolimus (Afinitor).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Kidney Transplant Recipients | Phase 4 | Status: UNKNOWN